for Grasser, then today. Joerg of joining highlights will Thank you will our quarter today I call you Officer. by financials. through afternoon, third our and very Financial begin our thank the Good am and run let Chief joined much. I everyone, today I Joerg with
for activities, the prepared of a our discussion analysts. our with line business the before development Finally with I will conclude opening Q&A remarks
We had quarter third productive many on a fronts. very
long Board we for capital starting human investment, Directors. growth, strengthened As of with term company our significantly our our we position
than contributes our each During new X XX experience. Independent the and Directors we months, three industry new Directors years more last of of have added
Terri and to expanding and valuable Graham advance within CB advertising creative carries and CBD thinking will Funk rapidly approach critical in we category brings industry. product to experience positioning First, our the prominence as the marketing be our our board, Sciences
more Paul experience drug of Dr. to smokeless Blake Blake, clinical our Dr. added decades oversight as towards who drug instrumental will in brings studies also we our than human company. three program. development We on development and guidance tobacco cessation move providing be
our over San KPMG, invaluable as Board last career industry. products And XXX Beth’s life for with science both recently of XX the joined provides Diego, most responsible her professionals week, and in consumer Partner Managing Altman year in with Beth Directors. office experience
proud join directors. We independent Terri, our Paul of Directors to have are Board as and extremely Beth,
of hands. five experience. of governance good independent directors include two numerous decades The Our Sciences physicians in relevant is have are and diverse, CV
industry, will along Also, President and marketing as we during position substantially Senior natural Communication. branding new initiative. with to future last Shane Vice we our several in we growth valuable be the have Hart products resources our creative our the months, background and invested in growth. as contribution added of a sales for recently, Most Shane's marketing Marketing capabilities his and company
the digital to and this returns fully investing strong provide future. marketing in also are expect in We heavily investment term near
products. and derived we is XXXX, In a Following have CBD hearing public to to consumer management FDA Sciences FDA late of and possible regulated to impact on current access dialogue that CB senior FDA. shared met the this discuss well the review during with hemp Maryland safe October The presentation and continued ensuring the up of scientific of our company's we with of new FDA scientists have hemp a derived safety natural on CV at dialogue FDA received reinforce in in regulation and XXXX, ingredients. meeting sciences goal May
has facility will it us of we today, invaluable efforts XXX% industry. MacKay Sciences established Dr. the current at quarter the is be Affairs, during addition the of with end by to operational derived This CV to XXXX. Scientific and consumer Duffy over responsible as our The increase we to expansion production framework the third our hemp partially that CBD operational of quarter production facility support to in Head capacity. a warehousing Further, FDA, announced engage product is as by Regulatory fully a been and regulatory of allow and first new expect partner
aimed expanding technology beat. CVD as to and our in relies investments category product scale are All human infrastructure these product and to capital, the brand operating positioning of keeps sciences at the and on CV
create are shareholders. and respected investments for leaders. And future value important more long even and long today, in These mainstream, matter be leading as with quality will our will to way expand as term a winners continues and this industry sciences be we term the high the will CB
while were productive results, the short impacted quarter third by very term factors. main Our two in
product an companies First, low increased CBD the to FDA, especially of which in category, to product barrier into channel. has very has the the absence led competition which entry led from for turn final regulatory framework the interim retail significantly a in or of natural new
uncertainty state many Continued by our regulatory created partners. affecting of ambiguity has also retail state
expect to to short in we we continue that and a we which impact, and result, be year-over-year, X% decline been reported a term have will revenue counteract. As
and current of the e-commerce let channels, performance conditions our on direct-to-consumer the channel, primary three Next, channel. provide of the FDM more the sales food, mass and and drug product me retail or each natural market detail channel,
was channel years retail the this five we and product leading brand in products. nearly natural channel. ago, category CBD this are the We of started still adopter first early and The
with shelf months, space is new to last which nine product product space the are Over giving for XXXX than Many away the obtain every has shelf unsustainable. been flooded natural brands, in competing state. perhaps companies simply space, more
that these not misleading leads efforts. and to have requirements confusion. companies that survive sales having do safety More retailers and low realize federal regulations will overall more quality on and and XX or the marketing quality of customer products shelf, due are brands labels to typically the We numerous will are lower mandate. to Additionally, majority the a very beginning believe
already on back most discussion number with are partners and products this and focusing only scaling such trusted shelf and CV brands our of retail the the quality about in We as channel in on companies Sciences. highest
the years We past channel are a in just pioneer and in this five space.
and know to West them quality support We current and normalizes. And the our our be safety not and only They that scale the will environment retail of our the longevity there products. but have Wild partners company. quality when the will trust also integrity we know also of and
only and The topical explains FDA cautious FDM an brands products. this resulted in rigorous, are the spite of there regulations in and for this In this the channel different, which why is few taking across that barrier-to-entry this is retailers absence major currently channel, products approach approach, of channel on-shelves includes has channel.
sourcing wants a scale categories to FDM apply Sciences, brand the the to support such FDM environment. high this diligence entered a to quality quality good and channel ability year, due and retailers choosing standards compete companies and and products, function in brand, The regulated CBD have CV operating their that in must the partners as
once channel the who to will established, the We of of variety a products. provides shortlist anticipate large long-term that regulations their the retailers the these category. FDA of opportunity. We in retailers requirements adjustable include significant CBD large meet companies expand leads are Sciences FDM CV believe CBD offering
our which The categories, compared current range one regulatory creates is of to product main for in retailers, sales large once the CBD a carried sales lower channel, FDM other by optimism reasons the CBD framework. significantly velocity topical this expand products typically to have FDA of
stores, in fully our credibility, when to shelf space, open openings shelf perform. in and to once is channel us place. store will leverage to regulatory Our current build these demonstrate our focus establish the and is an framework market relationships, space This FDA this opened, allow is continue relationships to obtain new ability
to CV positioned the product channel. Sciences brand market in our a leader well sustainable retail FDM extremely be is and for
is Our a third or channel. channel sales e-commerce direct-to-consumer
opportunity to technology us have initiatives expansion invested e-commerce digital marketing expansion. of and there the channel. important support underway growth in year, and We we this During we huge numerous past for sales support believe to is a have personnel, in heavily
We even be experience, over customer better we operational expect e-commerce which our revamping fully to an currently website for the are coming months.
companies the We We of remain and development sensible, product trusted CBD just are enthusiastic they consumers quality major and consumer and in as eager that to have migrate believe consumer the unfold. to see industry and regulations will continued for excited category. quality products focused all retailers and
future long-term number we CV is sustainable occurs, and the companies will more are and normalized of category shrink, a which As this eventually products reason in Sciences. another brands on environment bullish that the is creating respected, this of
compliant quality products, CV by with in policies. and All producing in and ourselves adherence of the CBD us Sciences highest to honest safest marketing leading labeling pride example, and our
will be We in a be alone. regulatory of the billion support compliance category growth focused market, the in term the continue estimated sources on long to CBD industry many to US $XX the and credible by leader product
Our the compliance in hemp number product continues one to establish the key channel. based and why regulatory in focus our selling we CBD and been with be early also strong on are have retail the quality, to channel, products line partners education retail foothold an natural and able reasons brand PlusCBD FDM
it to run to over turn Now, let Joerg financials. through our me
